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Abstract
Background: Plasmodium vivax merozoite surface protein 3α (PvMSP3α) is a promising vaccine candidate which
has shown strong association with immunogenicity and protectiveness. Its use is however complicated by
evolutionary plasticity features which enhance immune evasion. Low complexity regions (LCRs) provide plasticity in
surface proteins of Plasmodium species, but its implication in vaccine design remain unexplored. Here population
genetic, comparative phylogenetic and structural biology analysis was performed on the gene encoding PvMSP3α.
Results: Three LCRs were found in PvMSP3α block II. Both the predicted tertiary structure of the protein and the
phylogenetic trees based on this region were influenced by the presence of the LCRs. The LCRs were mainly B cell
epitopes within or adjacent. In addition a repeat motif mimicking one of the B cell epitopes was found within the
PvMSP3a block II low complexity region. This particular B cell epitope also featured rampant alanine substitutions
which might impair antibody binding.
Conclusion: The findings indicate that PvMSP3α block II possesses LCRs which might confer a strong phenotypic
plasticity. The phenomenon of phenotypic plasticity and implication of LCRs in malaria immunology in general and
vaccine candidate genes in particular merits further exploration.
Keywords: Low complexity regions, Antigenic diversity, Immune evasion, Vaccine design
Background
In the past genetic diversity studies have been carried
out to assess the circulating malaria parasite populations
to assist in the formulation of strategies for monitoring
and control interventions. Given that high diversity was
observed in malaria and specifically in P. vivax, it was
also important to identify the relevant polymorphisms
that contribute to antigenic escape and its potential to
develop a “vaccine resistant strain” [1]. To that end, a
number of studies have targeted antigenic proteins using
diversity covering approaches [2]. On the other hand,
population genetic studies can guide vaccine design by
predicting polymorphisms that contribute to antigenic
diversity [3]. For P. vivax especially, population genetic
studies are of paramount importance since it invades
only reticulocytes and is notoriously hard to grow con-
tinuously in in-vitro cultures [4]. This is mainly achieved
by recognizing polymorphic regions, and analyzing if the
regions are under balancing or immune selection. This
approach has led to substantial improvement in terms of
understanding how diversity plays a role in immune
escape mechanisms, but translation into current clinical
trials has been hampered due to how little mechanisms
underlying diversity have been studied. Most studies
have so far focused on point mutations and recombin-
ation overseeing other mechanisms such as the gener-
ation of low complexity regions (LCRs) or structural
adaptation of the proteins [5]. For Plasmodium
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species,this is perhaps most curious since LCRs are associ-
ated with host pathogen interaction and phenotypic plasti-
city, enhancing their role in evading the immune system
[6, 7]. This is in addition to the fact that LCRs are highly
frequent in Plasmodium parasite antigens.
PvMSP3α is a promising vaccine candidate with stud-
ies showing a strong association with immunogenicity
and protectiveness [8]. However due to its direct contact
with the immune system it is highly polymorphic with
clusters of repetitive regions [1]. Repetitive regions and
certain traits of phenotypic variation have been associ-
ated with low complexity regions (LCRs). LCRs contain
short segments of homo-polymeric repeats, or segments
that are over represented by a small number of residues
of aperiodic repeats which appear as a mosaic of repeats
[7]. LCRs mediate protein-protein interaction, and are
involved in host pathogen communication, and immune
evasion [9–13] . The influence of LCRs in MSP3α is ap-
parent; with implications in the genetic diversity [14], the
secondary structure of alpha (α) helices, its coiled-coil
tertiary structure and recombination hotspots [15, 16].
Particularly extensive recombination has been largely been
ascribed as the major reason behind the failure to link
specific alleles to geographical regions [17–19].
In essence, studying the molecular evolution respon-
sible for variations in PvMSP3α, by analyzing features
such as LCRs with respect to their role in B cell epitope
variability and geographical distribution is of utmost
importance to guide rational vaccine design for P. vivax
in this antigenic locus. In the present study, using se-
quence data derived from P. vivax clinical isolates in
patients from Ethiopia and genbank data, the nucleotide
and amino acid sequence of the PvMSP3α block II were
used to study evolution of the gene and potential conse-
quences with respect to its use as a subunit vaccine
candidate in light of LCRs.
Results
PvMSP3α gene subtypes and clonality of infection
Of the 50 dried blood spot (DBS) samples that were
confirmed for P.vivax infection, the MSP3α gene was
successfully amplified in 48 of the 50 samples. From the
band size of the amplification products, compared to the
molecular marker, 3 size variants were observed for
MSP3α gene: type A (1 .9kb, 39 (82.9%), type B (1 .5kb, 6
(12.7%)) and type C (1 .1kb, 3 (4.2%)). A single multi-
clonal sample with more than one band size was detected
among the 48 samples. Excluding this sample, restriction
digestion analysis using Hha I and Alu I, identified five
additional multi-clonal samples; making an overall 12.5%
(6/48) multiplicity of infection.
Of the total 15 samples that were sequenced for
PvMSP3α entire region; one of the samples was not of
sufficient quality. The three size variants observed
during the PCR amplification are, type A that ranged
from 1815 bp to 1925 bp, type B from 1407 bp to 1437
bp, and two representatives of type C‘s with a size of
1173 bp were observed. Type A variant sequences had
several insertion and deletions, as evident in the size dif-
ference between the smallest and the largest sequences
which amounted to 110 bp. Type B variants had an in-
tact 281 bp at the start of the sequence followed by a de-
letion of 435 bp and ending with an intact block II
compartment. The alignment of amino acid sequences
(Fig. 1) deduced from the 14 full and additional 23 block
II sequences from Ethiopian isolates and the reference
sequence PVX_097720 showed that block II is relatively
conserved compared to block I.
The polymorphism and genetic diversity of PvMSP3α
block II is limited to specific sites
Of the total 40 Ethiopian isolates sequenced for
PvMSP3α block II, three were deemed of low quality for
analysis (1 sequenced for the full region as described
above and 2 sequenced for block II region only). The
alignment of the block II 758 bp (n = 37) identified 38
variable sites, of which 29 were parsimony informative
(9 were singletons); 23 were non synonymous mutations.
Rich nucleotide diversity (π = 0.013) with 20 haplotypes
and a very high (0.953) haplotype diversity (Hd) was
observed. However, the extent of diversity varied in
different segments of the block, for instance superior
values of diversity were attained between positions 404
bp and 436 bp of the alignment where a diversity as high
as 0.22 was detected in this block (Fig. 2).
Majority of the known B cell epitopes in PvMSP3α block II
mapped in LCRs
Three LCRs interspersed within the 254 amino acid
residues that define the block II region of the PvMSP3α
were identified. The first LCR site spanned 29, the sec-
ond 69 and the third 51 amino acid residues. In total,
from the 254 examined residues, 158 (62.2%) were
amino acids that encompassed the LCRs (Fig. 1).
The three LCRs shared a significant abundance of
three amino acids; alanine, glutamic acid and lysine re-
spectively. Over representation was particularly evident
for alanine and lysine whose abundance spiked within
LCR sites as compared to their overall composition in
the block (Additional file 1: Table S1). For instance, the
abundance of alanine within LCR2 and LCR3 was 39%
as opposed to its overall composition (31%). Similarly,
for lysine in contrast to its 16% overall abundance;
within LCR1, LCR2 and LCR3, it had an abundance of
24, 20.29 and 21% respectively. Yet, the two high com-
plexity regions (HCRs) sites adjacent to these LCR sites
had lower abundance for alanine (24% & 15%) and lysine
(9% & 15%).
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Fig. 1 Multiple amino acid sequence alignment of the PvMSP3α block I and II with the reference sequence (PVX 097720). Shown in the left panel
is the PvMSP3α block I with the three size variants (a, b, c) indicated from top to bottom, respectively. In the right panel, the relatively conserved
PvMSP3α block II is indicated. The reference sequence (PVX_097720) was used to locate LCRs (red bars, imbedded within) and B cell epitopes
(purple arrow, below it) in block II region
Fig. 2 Sliding window plot analysis of nucleotide diversity in PvMSP3α block II in Ethiopian isolates. Histograms show the position (X-axis, bp
refers to base pair) and diversity level (Y-axis) circle indicates peak diversity level attained
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From the six known B cell epitopes within the block II
region (Table 1), four were mapped within LCR sites,
one each for LCR1 and LCR2 and two for LCR3 (Figs. 1
and 3). Curiously, also the two B cell epitopes found
within the HCR sites also extended to the start of LCR2
(Fig. 3). Another interesting feature was the presence of
repeats, particularly one located in a B cell epitope 1 em-
bedded within LCR1 and the other located within LCR2,
both exhibited the motif ‘AAAEEA’, while one is a B cell
epitope, the other is not (Fig. 1). Two of the three afore-
mentioned abundant amino acids, alanine and lysine,
were also over represented in these six epitopes. Most
notable was the abundance of lysine for LCR located B
cell epitopes, ranging from 21.43 to 33.33% as compared
to the two epitopes based on HCR site (7.14% &15.38%).
Whereas alanine is abundant throughout all six (28.57–
40%), and the abundance of glutamic acid was variable,
from as high as 28.57 to 0%.
B cell epitopes and its flanking regions contained
clustered polymorphic sites
In terms of amino acid polymorphism, a total of 37
amino acid mutations were observed in Ethiopian P.
vivax isolates, of which 22 were singletons. A total of 15
sites were parsimony informative. Eight of these muta-
tions were found in motif I and II (M/L E/K, K/E), (K/T,
E/A, T/N. A/V, D/L) which are B cell epitopes in this
block. Additionally, two amino acid changes were ob-
served in the first 50 amino acid residues of the block
(K/E, K/E, D/E), the first being within the B cell epitope
region. The two remaining amino acid changes were
found at residues 225 (D to N substitution) and 233 (K to
N substitution), and the latter substitution was specific to
Ethiopian P. vivax population. Whereas, the former sub-
stitution was only observed in two other isolates from
Ethiopia, Brazil (Belem strain, AF093584.2) and Thailand
(AY833015.1) but not observed in isolate sequences from
other geographic regions. Interestingly the D to N substi-
tution also lies in a previously characterized B cell epitope.
To map the global diversity of PvMSP3α block II
amino acid sequence, 142 (37 Ethiopian, and 105 global)
amino acid sequences derived from 12 populations were
used for analysis. From this an overall 26 parsimony
informative sites were observed in global isolates, 19
mapped to the 3 LCR sites and 14 of these were exclu-
sive to the B cell epitopes within these regions. Only 7
polymorphic sites were identified within HCR sites, with
4 of these lying within motif I. The analysis for the con-
servation of the 6 epitopes in block II region revealed a
peculiar variation. Four of the six epitopes located in the
LCR sites had mutations, in contrast to the 2 epitopes
found in HCR sites which remained conserved albeit low
frequency singletons in B cell epitope 2 (Table 1). B cell
epitope 4 specially had dimorphic alleles, with both forms
showing equivalent proportion in terms of abundance.
The other 3 epitopes (B cell epitope 1, 5, 6) also show
amino acid substitution even though the frequency of the
mutations was not as notable as that of B cell epitope 4.
To visualize the localization of the B cell epitopes and
LCR sites, the tertiary structure of the PvMSP3α block II
Table 1 B cell epitopes of the PvMSP3 block II from the database https://www.iedb.org/: the location of epitopes, amino acid
substitutions and the proportion of the variable amino acids were stated as observed by aligning 142 amino acid sequences from
18 populations
Epitope (IEDB) Region Found Position & Variable residues (substitutions) % Proportion
1) NDATEAKKQAEKAKAAAEEAKTHGEK LCR 1 K/N/H/E 68.6/28.7/1.1/1.1
8 E/K 79.8/19.7
2) KAYAVEAHLAKTKN HCR Singletons Only
3) DAANIAHQKWLKAT HCR Conserved Region
4) KAQKEATAAKLKA LCR 134 A/T 95.7/3.7
136 T/K/N/A 54.8/43.6/0.5/0.5
137 A/E 55.9/43.6
139 N/T 54.8/44.7
140 V/A 55.9/43.6
141 V/A 55.9/43.6
143 D/L/F 54.8/44.1
5) AEDAAEEAKEAAKK LCR 212 A/V 94.1/5.9
215 A/T/P 98.4/1.1
6) DKTIAAAKKAKKARE LCR 234 K/N 97.3/2.7
235 A/T 98.4/1.6
236 I/M 98.9/1.1
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protein was modeled; the predicted protein formed
α-helices with heptad repeats responsible for its tertiary
left handed coiled-coil structure (Fig. 3 a).
In terms of B cell epitope localization, the six epitopes
were mapped to the solvent exposed surface, further
elucidating their role in immune mechanism (Fig. 3 b,
Additional file 1: Table S1, Additional file 2: Table S2 and
Additional file 3: Figure S1). Also, most of the polymorphic
sites were clustered around or were in fact B cell epitope
sites. It is also important to note that there was no bias
regarding the location of polymorphisms as they seem to
be randomly distributed to all solvent accessible faces of
the tertiary structure (Fig. 3 c). As expected all polymor-
phisms in the 6 B cell epitopes sequences were in a manner
that did not disrupt the tertiary structure of the protein,
that is where hydrophobic amino acids were substituted by
similar non polar side chains and hydrophilic amino acids
substituted by similar amino acid chains.
Phylogeny, signatures of balancing selection and
recombination in the genes encoding PvMSP3α
Two phylogenetic trees were reconstructed using Bayes-
ian inference, and maximum likelihood. In both cases,
trees showed lack of obvious geographical structuring,
for instance isolates from Ethiopia (red) were distrib-
uted in mini clusters and found in different parts of
the cladogram, as was the case for most of the other
isolates (Fig. 4).
For block II, apart from phylogenetic trees, evidence of
population structuring was also minimal as observed
using FST estimates for both local and global phylogen-
etic alignments, indicative of extensive gene flow. In-
stead, the phylogenetic tree clades were clustered based
on the structural motif I & II dimorphic alleles. In
addition, recombination was observed from isolates of
different geographic origins and between different PCR
size classes and throughout the phylogenetic tree gener-
ated by the RDP program. Similarly, a minimum of 6
recombination events (rm) were detected by Dnasp in
the Ethiopian P. vivax population. These sites include
those under balancing selection (motif I & motif II).
Apart from this, RDP program identified 4 breakpoint
events. These sites experiencing recombination were
largely within LCR sites or sites immediately next to it.
For instance motif II, which is under balancing selection
and experiencing frequent intragenic recombination, lies
Fig. 3 The predicted tertiary left handed coiled coil structure of PvMSP3α block II protein. Indicated in a) is the heptad repeat sequences
(‘abcdefg’ configuration) and location within LCRs responsible for the tertiary structure, b) location of B cell epitopes (arrow) and LCR sites (red) in
the tertiary structure, c) polymorphic sites in PvMSP3α block II (yellow) as investigated after aligning all global block II protein sequences
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within LCR2. Similarly, motif I which also experiences
notable recombination lies adjacent to LCR2.
To test for signs of balancing selection, the number of
synonymous substitutions per synonymous site (dS) and
non-synonymous substitutions per non-synonymous site
(dN) was calculated. Accordingly the null hypothesis
(H0:dN = dS) and the alternative purifying selection (dN
< dS) were rejected at significant values of P = 0.049 and
P = 0.026 respectively. Additionally, calculated frequency
based tests of Tajima’s D and Fu and Li’s F tests were
0.702 (P>0.100) and 0.337 (P>0.100), respectively cor-
roborating the aforementioned result. However, window
plot analysis with window size of 11 bp and step length
of 1 revealed significant value of Fu and Li’s F between
the 387 bp and the 443 bp LCR region. Similarly the
Tajima’s D statistic showed significant values between
positions 399 bp–437 bp (Fig. 5). In this region Fu and
Li’s F statistic was 1.762 (P>0.050), Tajima‘s D was 2.640
(P>0.050). The observations indicate that the small re-
gion with significant values of the parameters were
under balancing selection. Comparative analysis of the
24 bp region encoding motif II revealed significant
values of Fu and Li‘s F 2.291(P < 0.020) and Tajima’s D
3.230 (P < 0.001). Whereas the rest of the block minus
the motif II sequence (693 bp) revealed significant values
of − 5.323(P < 0.002) of Fu& Li’s F and − 2.566(P < 0.001)
of Tajima‘s D. This region that encodes structural motif
II, has dimorphic alleles TAANVVKD and KEATAAKL,
indeed another region (motif I) with a dimorphic allele
was also identified (MSELEK and LSKLEE) at a LCR
adjacent part of the gene. Although its dimorphism was
at a lesser extent in the Ethiopian P. vivax isolates. In
contrast, the dimorphic alleles of motif II were equally
prevalent (1:1) in the isolates.
To further understand the impact of population struc-
ture or lack thereof on haplotypes, a network was drawn
using the median joining algorithm (Fig. 6). To focus on
the haplotypes that were frequent in the world and rele-
vant to vaccine design, only non-synonymous variations
that were seen in more than two isolates were used to
construct the haplotypes. While the focus of the study
was primarily the Ethiopian population, the haplotype
network was derived from the 26 (non-synonymous)
haplotypes of 12 populations. Accordingly 9 haplotypes
with prominent frequency were commonly observed in
the populations. Three haplotypes were observed in 51%
of the isolates in this study, the most frequent haplotype
included sequences from populations of Ethiopia, Sri
Lanka, Papua New Guinea, Venezuela, Thailand,
Myanmar, Vietnam and Panama. The second most fre-
quent haplotype 1 also included sequences from the
above populations as well as from Brazil, Ecuador, South
Korea, India and Mauritania. The two haplotypes repre-
sent 13 of the 17 P. vivax endemic countries included in
this study.
Discussion
PvMSP3α block II domain is one segment of a vaccine
candidate antigen that appears relatively conserved
amongst global P. vivax isolates and has hence garnered
more studies. This was also evident in the nucleotide
diversity observed for the Ethiopian P. vivax population
(0.014and haplotype diversity 0.953), which was compar-
able with other endemic countries; that ranged π
Fig. 4 Phylogenetic trees based on PvMSP3α block II amino acid sequences from different geographical origins. Phylogenetic trees constructed
using a) Bayesian inference (left) and b) maximum likelihood tree (right) based on block II sequences. The label of each sequence is color coded
corresponding to the country of origin
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0.015(Brazil) to 0.023(India) while the global diversity
stood at 0.019 [20]. Previous studies have also indicated
that polymorphism was limited to specific sites of the
block, this was also true for Ethiopian isolates; at and
around motif I and motif II where π could be as high as
π = 0.22 [19]. These peculiar patterns of genetic diversity
are attributes of the functional constraints that are
placed upon block II. Interestingly prior studies have
shown that the alanine rich domain of block I and II are
hot spots for recombination, but being particularly
higher for block II than in block I where it could be 2 to
5 times higher [18, 21] . Indeed meiotic recombination
is a common phenomenon in malaria antigens that is
favored by multi-clonal infections, another recurring
theme of P. vivax infections, which was higher in our
study (12.8%) like previously reported [22] for multipli-
city of infections.
Given the history of this block as a potential vaccine
candidate that is also a hot spot for recombination, it
was important to characterize intragenic recombination
events and assess their contribution in evading the
immune system. High frequency of recombination
events combined with evidence of polymerase template
slippage reported in prior studies, led to the hypothesis
that LCRs might be present in this gene [18, 19]. This is
largely because both mechanisms are associated with the
origin of LCRs, but also because LCRs are common fea-
tures in surface antigens of Plasmodium species [7, 18].
This was confirmed in this study by using the SEG
algorithm. Particularly for block II, 3 LCRs were found
interspersed within the domain. Furthermore, the associ-
ation between recombination and LCRs was also con-
firmed. A minimum of 6 recombination events (rm)
were detected in the Ethiopian P. vivax population.
These sites experiencing recombination were largely
within LCR sites or sites immediately next to it. For
instance motif II, which is under balancing selection and
experiencing frequent intragenic recombination, lies
within LCR2. Similarly motif I, who also experiences
notable recombination, lie adjacent to LCR2. These two
motifs are interesting since both were particularly pre-
dicted to be B cell epitopes in previous in vitro and in
Fig. 5 Sliding window plot analysis of signatures of selection on PvMSP3α block ii in Ethiopian sequences: Fu & li’s F (green) and Tajima’s D (Red)
test values (X-axis) are indicated using a window size of 11 and step size of 1 bp (Y-axis)
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silico studies (http://www.iedb.org/) [20]. Additionally
since diversity in genes encoding antigens especially on
the sporozoite and merozoite result from natural
selection imposed by the immune system [23], we also
performed tests of neutrality. Consequently test for
neutrality was rejected at a significant value (P = 0.049,
P < 0.050). Similarly the negative selection hypothesis
was rejected at (P = 0.026,P < 0.05), suggesting that posi-
tive selection might be operating on block II. This find-
ing is quite similar to the ones observed in a study by
Rayner and colleagues in these antigen loci [19]. In posi-
tive selection, genetic variants favored by this pressure
will either increase in frequency or be maintained, as has
been the case for P. falciparum vaccine candidate anti-
gens such as MSP-1, MSP-2, TRAP and AMA-1 [24].
Although in the current study, positive values were ob-
served for both Tajima‘s D and Fu and Li‘s F across the
length of the block II, highly significant values were
observed only in one specific region, the LCR region en-
coding motif II. Further comparative analysis of the
structural motif II (24 bp) and rest of the block (692 bp)
also revealed a highly significant positive value for both
tests in the structural motif II. In contrast, the rest of
the block had significant negative values. This would
indicate that, while positive selection is operating on the
entire block thus reducing diversity, the small region
encoding motif II is under balancing selection (Immune
selection). As further evidence on the effects of balan-
cing selection, genetic differentiation estimates for se-
lected population sequences revealed low FST estimates
(data not shown). Moreover, FST values between
Ethiopian and Brazilian (FST = − 0.02), Ethiopian and Sri
Lankan MSP3α block II isolates (FST = 0.025) are lower
than values attained using single nucleotide polymorph-
ism markers (SNP) for both pairs (Ethiopia and Sri lanka
FST = 0.21; Ethiopia and Brazil FST = 0.31) [25]. However,
this data should be interpreted with caution because of
the small sample size in the study.
The lack of geographical structuring was further
supported by phylogenetic tress that were constructed
using global sequences from 12 populations using block
II domain. These results are consistent with those of
other studies and suggest that phylogenetic inference
alone may not be sufficient in vaccine design using this
protein [17, 18, 21, 26]. From the constructed haplotypes
of block II, 3 of the haplotypes were shared in 51% of
the sequences included in the current study. The results
were more positive than the vaccine candidate antigen
Fig. 6 Haplotype Network for global P.vivax sequences that represent PvMSP3α block II region. Haplotypes were constructed from non-synonymous
(n = 26) variations, each color represents a specific population (n = 12) as outlined by the legend. Node sizes represent frequencies and lines represent
the mutational pathways
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PvAMA-1, where only 15% of the haplotypes were
shared among studied global isolates [27]. However it is
also important to bear in mind that due to the limited
number of samples, results should be interpreted with
caution. Apart from allelic diversity and given that this is
a surface protein other immune evading mechanism are
also likely, as reviewed in Ferreira et al., 2004 [13]. One
possibility is the generation of LCRs, which have been
associated with both protein-protein interaction as well
as immune evasion. LCRs were identified with biased
composition sharing a significant abundance of 3 amino
acids; alanine, glutamic acid and lysine. Curiously, a re-
peat of ‘AAAEEA’, was found embedded within LCRs;
one serving as a B cell epitope while the other is not.
This might indicate immune mimicry affecting antibody
affinity maturation and hence lowering the efficiency of
response to critical epitopes [12].
The PvMSP3α protein was predicted to form α-helix
structure with heptad repeats responsible for its tertiary
left handed coiled-coil structure as described earlier
[16]. Interestingly, most of the known B cell epitopes
were found within this LCR sites; in addition LCRs
dominate solvent exposed side of the protein in sharp
contrast to their high alanine (hydrophobic) content.
This might be counterintuitive; however alanine is a
small amino acid that is not particularly homophobic
and hence tolerated on protein surfaces. Additionally the
amphipathic nature of the heptad repeats also supports
this configuration;-Moreover, the high alanine content in
LCRs is equivalent to the combined abundance of the
polar amino acids lysine and glutamic acid. In terms of
B cell epitope localization, all 6 analyzed epitopes were
solvent exposed. Furthermore most of the polymorphic
sites were clustered around or were in fact B cell epitope
sites elucidating their role in immune mechanism. It is
also important to note that there was no bias regarding
the location of polymorphisms as they seem to be
randomly distributed to all solvent accessible faces of
the tertiary structure. As expected all polymorphisms in
the 6 B cell epitopes sequences were in a manner that
didn’t disrupt the tertiary structure of the protein, that is
where hydrophobic amino acids would be substituted by
similar non polar R groups and hydrophilic amino acids
would be substituted by similar R groups. However, even
in such like-for-like substitutions the observed alanine
substitution warrant further investigation, since alanine
mutations have been shown to decrease immune-re-
activity in previous studies using Apical membrane anti-
gen 1 of P. falciparum [28]. The reason behind this
reduced immunogenicity imparted by alanine residues is
thought to be the result of its rigid nature resulting in
loss of epitope flexibility and hence reduction in anti-
body binding [28]. As such it is also critical to assess
substitution polymorphisms in-terms of their structural
impact. Hence the peculiar variation of motif II, a B cell
epitope with alternate dimorphic alleles (TAANVVKD/
KEATAAKL represents a clinically relevant finding not
only due to its dimorphism but also because of struc-
tural consequences of this substitutions. To further
complicate matters, LCRs are also associated with
phenotypic plasticity, and given the proteins dependence
in block II domain for peripheral association with other
proteins, in addition to the surface proteins involvement
in merozoite invasion; it is likely that antigenic diversity
mechanisms described for invasion ligands Erythrocyte
binding antigen (EBA) and reticulocyte binding-like
homologous (PfRH) protein also apply here [29–31].
Conclusion
The abundance of LCRs in PvMSP3a block II has con-
tributed/influenced the tertiary structure of the protein.
Furthermore there is an enhanced site preference of
balancing selection, recombination and repeat motifs to
map on LCRs. The predicted B cell epitopes were also in
or adjacent to the LCRs which indicate the strong
phenotypic plasticity associated with this domain. Thus
our results are indicative of LCRs contribution toward
immune escape mechanisms and lack of geographic
clustering in PvMSP3α block II.
Materials and methods
Study area, sample collection, and ethics statement
The study was conducted between 2012 and 2013 at
Shewa Robit town health center (9° 59′ 40.6″N and 39°
53′ 48.9″E) and five health facilities in Shala district; Aje
(7° 17′ 34.2″N and 38°21′ 46.3″E), Bure (7°15′ 7.25°N
and 38° 29′ 38.4833°E), Haposto (6.7377904 and
38.3691932), Ilala (8°55′ 28.27″N,39° 50′35.90″E) and
Melka Oda hospital (l7°13′ 7.2167°N 38°29′ 38.4833°E).
Finger prick blood samples were collected to prepare
thin and thick blood films for parasite identification
using microscopy and dried blood spots (DBS) on What-
mann 3MM filter papers.
Species identification, amplification of the PvMSP3α gene
and restriction digestion
Genomic DNA was extracted by Chelex-Saponin dual
extraction method [32] from 6mm diameter DBS
punches. Nested polymerase chain reactions (nPCR) that
targeted the 18S small subunit rRNA gene were run to
confirm species of malaria infections [33, 34].
The block I and II of the PvMSP3α genes were ampli-
fied using primers and PCR conditions described before
[35]. Nested PCR products were then digested using two
endonucleases, Hha I (Promega, USA) and Alu I (Sigma
Aldrich, USA) using reaction conditions described before
[36]. The PCR products were visualized on 0.8% agarose
gel (AGCT ltd, USA) and digested products were run
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using 1.8% agarose and 1 kb plus molecular ladder (Invi-
trogen, USA) alongside for estimating sizes of products.
Sequencing and population genetic analysis
Polyclonal infections were first discerned from mono
infections by using PCR-RFLP procedure as reported by
Bruce and colleagues [35]. PvMSP3α nested PCR prod-
ucts were then purified using the QIAquick PCR purifi-
cation kit (QIAGEN, Germany,) and the template was
sequenced using outer and internal primers, as described
before [36]. Consequently, samples targeting the entire
block (I and II) and additional 25 samples targeting
block II region only were sequenced twice, both in for-
ward and reverse direction, using the Big Dye terminator
sequencing kit and the ABI Prism 310 Genetic analyzer
(Applied Bio-systems, base clear, The Netherlands).
Sequences were first inspected visually to ensure
correct base calls of the chromatogram data using
Chromas (version 2.6.4, Technelysium LTD). The low
quality regions were trimmed, assembled, and individu-
ally aligned using ClustalW [37] to two MSP3α reference
sequences; the Belem (AF093854) and Salvador strain
(PVX_097720) using SeqMan Pro 14 (Lasergene 14 soft-
ware, DNASTAR Inc.).
To study the phylogenetic relationships among block I
and II sequences both aligned nucleotide and deduced
amino acid sequences were used. Trees were constructed
using the maximum likelihood with Tamura and Nei
model of nucleotide substitution for nucleotide align-
ments [38] and the Jones Taylor Thronton model of
amino acid substitution method for amino acid align-
ments [39] with 1000 bootstrap replicate support for
both using the MEGA7 software (Version 7.0.21). Fur-
thermore, phylogenetic trees were also constructed for
both blocks using Bayesian inference as implemented by
Mr. Bayes (Version 3.2.6) using a general time reversible
gamma evolutionarily invariable (GTR +G + I) model.
Results were acquired after using 39 × 106 MCMC steps
and convergence was reached, subsequently 50% of the
samples were discarded as burn-in.
The Dnasp Software (Version6.10.04, Universitat de
Barcelona) was used to explore sequence diversity; such
as, the number of polymorphic sites (S), within population
and overall nucleotide diversity (π), number of haplotypes
(H) and haplotype diversity (Hd) [40]. To determine
genetic differentiation, Wrights Fixation index FST was
tested through 1000 random permutations [41]. To assess
departure from neutrality and examine if regions were
under selection, the number of synonymous substitutions
per synonymous site (dS) and non-synonymous substitu-
tions per non-synonymous site (dN) was calculated using
the modified Nei Gojobori method [42]. The null hypoth-
esis of neutrality (H0: dN = dS), and alternative hypothesis
of positive selection (dN > dS) and purifying selection (dN
< dS) were tested using a two tailed Z test for neutrality
and one tailed Z test for either of the alternative hypoth-
esis. Standard errors were computed through 1000 boot-
strap replicates. Furthermore, Tajima‘s D [43] Fu and Li‘s
F [44] were applied using a sliding window approach to
investigate signatures of balancing selection. Finally Dnasp
was used for haplotype construction. NETWORK (Ver-
sion 5.0.0.1, Fluxus Technology Ltd) was used to create
and visualize haplotype networks by applying the median
Joining algorithm. To detect recombination signals RDP4
program was used [45]. In order to analyze the dataset
generated in this study to a global context, 126 MSP3α se-
quences from 17 P. vivax endemic countries were retrieved
from genebank (http://www.ncbi.nlm.gov/genbank).
Low Complexity Regions (LCRs) of the PvMSP3α,
Salvador strain (PVX_097720) and the Belem reference
sequence (AF093584) was detected using the SEG algo-
rithm, http://mobidb.bio.unipd.it/. Tandem repeats were
detected using Ugene (v 1.29) and XSTREAM, http://
jimcooperlab.mcdb.ucsb.edu/xstream/. LCRs were deter-
mined using the SEG algorithm as specified before [46, 47].
Further, to analyze variable site across B cell epitopes,
experimentally identified epitopes were extracted from the
Web server (http:/https://www.iedb.org/).
Structural modeling of PvMSP3α
Since there are no homologous proteins specified to date
for neither the PvMSP3α nor reliable templates to per-
form homology modeling, an Ab initio method was used
to determine the tertiary structure. Accordingly the
ROBETTA server, http://robetta.bakerlab.org/, was used
to construct 10,000 decoys for PvMSP3α Salvador strain
(PVX_097720) filtered and clustered based on the
root-mean-square deviation of atomic positions (RMSD),
subsequently the top 5 models were chosen based on
lowest probability density function (PDF) [48]. The
models were then further evaluated in the ResProx
(http://www.resprox.ca/) and Vadar (http://vadar.wishar-
tlab.com/index.html) servers [49, 50]. Finally, they were
annotated using the Discovery studio visualizer version
17.2 (Accelrys, San Diego, CA). The Ab Initio methods
of the I-Tasser (https://zhanglab.ccmb.med.umich.edu)
and QUARK as well as the University of reading server
IntFOLD3 (http://www.reading.ac.uk/bioinf/IntFOLD/)
were also used to compare each of their models [51, 52].
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